Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 28, 2014 11:44:18 GMT -5
From the NYT article. See last sentence, is this true?
<<……MannKind also has not signed up a larger pharmaceutical company to help market Afrezza, even though it has said for years that it was in discussions with potential partners. The approval “is obviously going to help that process,” Matthew J. Pfeffer, the company’s chief financial officer, said in an interview on Friday, adding that Afrezza would not be available to patients until a partner was ready. >>
|
|
|
|
Post by kc on Jun 28, 2014 13:28:40 GMT -5
Don't worry! it will happen very fast......
I think that they have identified a partner for the product and will be making that announcement sooner then later. they have to have production ready and samples to send out to the marketplace and to Doctors. So you can bet that something good will happen within the next 30 days. They will want the samples and packaging to reflect what partner or brand will be marketing Afrezza...... Count on the partnership announcement or buyout happening soon.
The bears will continue to drive the price up and down and make the market react. But with all the positive press its getting world wide we will be able to have a great week. Just Google under the news section and you get 100's of stories on the FDA approval. This will continue to multiply over the weekend . The brokers will start to recommend and push mannkind as they are marketing machines and won't let just RBC be the market maker on MNKD.
STAY LONG MANNKIND...
|
|
|
|
Post by thekindaguyiyam on Jun 28, 2014 16:16:25 GMT -5
From the NYT article. See last sentence, is this true? <<……MannKind also has not signed up a larger pharmaceutical company to help market Afrezza, even though it has said for years that it was in discussions with potential partners. The approval “is obviously going to help that process,” Matthew J. Pfeffer, the company’s chief financial officer, said in an interview on Friday, adding that Afrezza would not be available to patients until a partner was ready. >> I get that you really have no clue who you are speaking to. Any confidence you have in trying to sway investor confidence here is pure motley foolishness. enjoy your ride; I'm sure you earned it. |
|
|
|
Post by Chris on Jun 28, 2014 16:18:18 GMT -5
I've been telling people about Afrezza left and right ever since yesterday's approval and everyone here in the Marina is loving it and asking for the name of the product for a family or friend. I was planning on going to the Bahamas next week or so but now I'm just going tomorrow! Hahaha what a ride.
|
|
|
|
Post by thekindaguyiyam on Jun 28, 2014 16:50:38 GMT -5
|
|
|
|
Post by BD on Jun 28, 2014 17:33:18 GMT -5
From the NYT article. See last sentence, is this true? <<……MannKind also has not signed up a larger pharmaceutical company to help market Afrezza, even though it has said for years that it was in discussions with potential partners. The approval “is obviously going to help that process,” Matthew J. Pfeffer, the company’s chief financial officer, said in an interview on Friday, adding that Afrezza would not be available to patients until a partner was ready. >> I get that you really have no clue who you are speaking to. Any confidence you have in trying to sway investor confidence here is pure motley foolishness. enjoy your ride; I'm sure you earned it. Well... we've certainly had some questionable characters come on the board lately, but I honestly do not think avogadro's post is sufficient grounds for lumping him in with the riff-raff! He's just asking what seems like a perfectly reasonable question. Can we please hold our fire until we can truly see the whites of thier eyes? Thanks... |
|
|
|
Post by thekindaguyiyam on Jun 28, 2014 17:53:02 GMT -5
I get that you really have no clue who you are speaking to. Any confidence you have in trying to sway investor confidence here is pure motley foolishness. enjoy your ride; I'm sure you earned it. Well... we've certainly had some questionable characters come on the board lately, but I honestly do not think avogadro's post is sufficient grounds for lumping him in with the riff-raff! He's just asking what seems like a perfectly reasonable question! Can we please hold our fire until we can truly see the white's of thier eyes? Thanks... You are the moderator. Excuse my sensitivity to those who I perceive as having intent to cause concern. Our views differ; and I do not consider what I rendered to be over the top hostile. Still, I will consider your flexibility with this poster; but retain my autonomous interpretation as to what is. I suppose a little more tolerance on my part will be considered because I respect your views. |
|
|
|
Post by BD on Jun 28, 2014 18:01:20 GMT -5
Thanks, iyam. I still remember the first time I ever posted on a financial message board; I was a bit afraid to ask questions, because I saw the way those who asked them were getting pilloried... and as it turns out, that company ended up being a scam, and all the folks who'd been the most attacked were the ones who were actually right. And I spent a lot longer than I'm proud of being one of the attackers. Since you just never really know (well, that doesn't apply here of course, but just on general principles...) it pays to give relatively new posters the benefit of the doubt. A good policy is, "If you're not sure, don't attack", and also, take a cue from the way some of the other old-timers (in terms of years of MNKD investing, not age bracket, lol) react.
Remember that every member's post history is a matter of public record here. Just click on their name and view their posts. A bit of DD never hurts...
|
|
|
|
Post by thekindaguyiyam on Jun 28, 2014 18:27:50 GMT -5
From the NYT article. See last sentence, is this true? <<……MannKind also has not signed up a larger pharmaceutical company to help market Afrezza, even though it has said for years that it was in discussions with potential partners. The approval “is obviously going to help that process,” Matthew J. Pfeffer, the company’s chief financial officer, said in an interview on Friday, adding that Afrezza would not be available to patients until a partner was ready. >> Apologies to you Avogadro. BD is correct about doing the DD. I read your body of posts and had I done that first I would not have responded to you as I did. Best of luck to you. I apologize. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 29, 2014 9:08:42 GMT -5
Apology accepted.
|
|
